<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). Abstract Purpose Breast" exact="cancer" post="is the most common malignancy among women across the"/>
 <result pre="to improve the prevailing treatment modalities, the overall prognosis of" exact="breast cancer" post="remains unsatisfactory. Recently, antiproliferative activity of Brevilin A (Brv-A),"/>
 <result pre="improve the prevailing treatment modalities, the overall prognosis of breast" exact="cancer" post="remains unsatisfactory. Recently, antiproliferative activity of Brevilin A (Brv-A),"/>
 <result pre="lactone compound of Centipeda minima, has been unveiled in various" exact="cancer" post="types. Here, we have explored anticancer activity of Brv-A"/>
 <result pre="be one of the potential anticancer therapeutics in future. Keywords" exact="breast cancer" post="Brevilin A apoptosis ROS ER stress STAT3 mitochondrial dysfunction"/>
 <result pre="one of the potential anticancer therapeutics in future. Keywords breast" exact="cancer" post="Brevilin A apoptosis ROS ER stress STAT3 mitochondrial dysfunction"/>
 <result pre="ER stress STAT3 mitochondrial dysfunction fig-count: ref-count: page-count: Introduction Currently," exact="cancer" post="research has been privileged over the last century due"/>
 <result pre="privileged over the last century due to multiple factors. All" exact="cancer" post="types including breast cancer have immersed the researcher’s attention"/>
 <result pre="last century due to multiple factors. All cancer types including" exact="breast cancer" post="have immersed the researcher’s attention to the devastating aspects"/>
 <result pre="century due to multiple factors. All cancer types including breast" exact="cancer" post="have immersed the researcher’s attention to the devastating aspects"/>
 <result pre="all female cancers and 18% of total deaths related to" exact="cancer" post="in both males and females.1,2 Incidence and prevalence rate"/>
 <result pre="in both males and females.1,2 Incidence and prevalence rate of" exact="breast cancer" post="is higher in North America, Northern and Western Europe,"/>
 <result pre="both males and females.1,2 Incidence and prevalence rate of breast" exact="cancer" post="is higher in North America, Northern and Western Europe,"/>
 <result pre="to Eastern Asia.3 In China, however, the incidence rate of" exact="breast cancer" post="has increased in last three decades by 20 to"/>
 <result pre="Eastern Asia.3 In China, however, the incidence rate of breast" exact="cancer" post="has increased in last three decades by 20 to"/>
 <result pre="decades by 20 to 30% and, according to Chinese urban" exact="cancer" post="registries, it amounts about 3–5% each year.4,5 This rise"/>
 <result pre="of a patient’s history, characteristics and pathology of the disease," exact="breast cancer" post="is managed by different strategies including surgery, radiation therapy,"/>
 <result pre="a patient’s history, characteristics and pathology of the disease, breast" exact="cancer" post="is managed by different strategies including surgery, radiation therapy,"/>
 <result pre="A lot of potential anticancer drugs are known for killing" exact="cancer" post="cells by enhancing ROS level.13,14 Traditional Chinese Medicines (TCM)"/>
 <result pre="anti-inflammatory and antiproliferative effects and exhibits anticancer activities in multiple" exact="cancer" post="types promoting oxidative stress, mitochondrial dysfunction and more specifically"/>
 <result pre="mechanism and mode of cell fatality is still unknown against" exact="breast cancer." post="The current study aimed to investigate cytotoxic and growth"/>
 <result pre="investigate cytotoxic and growth inhibitory effect of Brv-A in MCF-7" exact="breast cancer" post="cells along with underlying mechanism. In our study, ROS"/>
 <result pre="cytotoxic and growth inhibitory effect of Brv-A in MCF-7 breast" exact="cancer" post="cells along with underlying mechanism. In our study, ROS"/>
 <result pre="multi-pathway targeting property of Brv-A augments its role as potential" exact="breast cancer" post="therapeutics in future. Materials and Methods Chemicals and Reagents"/>
 <result pre="targeting property of Brv-A augments its role as potential breast" exact="cancer" post="therapeutics in future. Materials and Methods Chemicals and Reagents"/>
 <result pre="were obtained from Sigma-Aldrich. Cell Culture Human MCF-7 and MDA-MB-231" exact="breast cancer" post="cell lines were purchased from American Type Culture Collection"/>
 <result pre="obtained from Sigma-Aldrich. Cell Culture Human MCF-7 and MDA-MB-231 breast" exact="cancer" post="cell lines were purchased from American Type Culture Collection"/>
 <result pre="cytotoxic effect of Brv-A in MCF-7 as well as MDA-MB-231" exact="breast cancer" post="cell lines. Following CCK-8 assay, Brv-A was found effective"/>
 <result pre="effect of Brv-A in MCF-7 as well as MDA-MB-231 breast" exact="cancer" post="cell lines. Following CCK-8 assay, Brv-A was found effective"/>
 <result pre="was found effective against both triple positive and triple negative" exact="breast cancer" post="cells (Figure 1A and B). The calculated IC50 value"/>
 <result pre="found effective against both triple positive and triple negative breast" exact="cancer" post="cells (Figure 1A and B). The calculated IC50 value"/>
 <result pre="aimed to explore anticancer effect of Brv-A in triple positive" exact="breast cancer" post="type, we selected MCF-7 cell line as a model"/>
 <result pre="to explore anticancer effect of Brv-A in triple positive breast" exact="cancer" post="type, we selected MCF-7 cell line as a model"/>
 <result pre="Consistent with CCK-8 and live/dead assay results, data demonstrated remarkable" exact="suppression" post="in colony formation in MCF-7 cells. Furthermore, we quantified"/>
 <result pre="data demonstrate that Brv-A induces ROS-dependent mitochondrial apoptosis in MCF-7" exact="breast cancer" post="cells. In earlier studies, it has been verified that"/>
 <result pre="demonstrate that Brv-A induces ROS-dependent mitochondrial apoptosis in MCF-7 breast" exact="cancer" post="cells. In earlier studies, it has been verified that"/>
 <result pre="&amp;lt;0.05, ###p &amp;lt;0.001 vs 15 µM treated group. In various" exact="cancer" post="types, Janus kinase (JAK)-signal transducer and activator of transcription"/>
 <result pre="that Brv-A induced STAT3 inhibition is ROS-dependent and associated with" exact="suppression" post="of upstream tyrosine kinases. However, further study is needed"/>
 <result pre="time period. We measured the expression of well-known markers of" exact="cancer" post="invasion and metastasis including cyclooxygenase-2 (COX-2) and matrix metalloproteinase"/>
 <result pre="Collective data demonstrate that Brv-A has antimetastatic activity in MCF-7" exact="breast cancer" post="cell line. Figure 6 Effect of Brv-A on cell"/>
 <result pre="data demonstrate that Brv-A has antimetastatic activity in MCF-7 breast" exact="cancer" post="cell line. Figure 6 Effect of Brv-A on cell"/>
 <result pre="**p &amp;lt;0.01, ***p &amp;lt;0.001 vs untreated group (control). Discussion Currently," exact="breast cancer" post="has become a serious concern across the whole globe.32"/>
 <result pre="&amp;lt;0.01, ***p &amp;lt;0.001 vs untreated group (control). Discussion Currently, breast" exact="cancer" post="has become a serious concern across the whole globe.32"/>
 <result pre="radiotherapy, and hormonal manipulation are the possible approaches to eradicate" exact="cancer" post="which already has an improved five-year survival rate in"/>
 <result pre="cancer.33 Development of resistance against conventional therapies ultimately leads to" exact="cancer" post="metastasis and recurrence. Most of the primeval antitumor drugs"/>
 <result pre="of the primeval antitumor drugs have limited approach to kill" exact="cancer" post="cells, i.e. development of single drug for single target.34"/>
 <result pre="asthma.15,37 Recently, Brv-A has shown antiproliferative activity in various human" exact="cancer" post="types including CT26, A875, HeLa, HepG2 and A549 cell"/>
 <result pre="cell line.38 However, anticancer activity of Brv-A in triple positive" exact="breast cancer" post="cells has not been investigated so far. Cancer cells"/>
 <result pre="line.38 However, anticancer activity of Brv-A in triple positive breast" exact="cancer" post="cells has not been investigated so far. Cancer cells"/>
 <result pre="cell proliferation, cell survival, angiogenesis, and metastasis.39,40 This property of" exact="cancer" post="cells has been therapeutically exploited for profitable purpose. Recently,"/>
 <result pre="Recently, ROS based drug advancement has become major attribute for" exact="cancer" post="management irrespective of its heterogeneity and genotype.41–43 In this"/>
 <result pre="significantly inhibited viability of both triple positive and triple negative" exact="breast cancer" post="cell types, however, only triple positive MCF-7 cells were"/>
 <result pre="inhibited viability of both triple positive and triple negative breast" exact="cancer" post="cell types, however, only triple positive MCF-7 cells were"/>
 <result pre="study where a sesquiterpene lactone, deoxyelephantopin, inhibited proliferation of HepG2" exact="liver cancer" post="cells by promoting ROS generation.21 Further, we were interested"/>
 <result pre="where a sesquiterpene lactone, deoxyelephantopin, inhibited proliferation of HepG2 liver" exact="cancer" post="cells by promoting ROS generation.21 Further, we were interested"/>
 <result pre="are well-known compounds for inducing apoptotic cell death in various" exact="cancer" post="cell types.44 These compounds have also been confirmed to"/>
 <result pre="stimulus disrupts mitochondrial membrane potential by decreasing Bcl-2/BAX ratio in" exact="cancer" post="cells and releases cytochrome c from mitochondrial inter-membrane space"/>
 <result pre="where Brv-A has been shown to induce apoptosis in various" exact="cancer" post="cells.15,17 ROS generation has been documented to induce ER-stress"/>
 <result pre="documented to induce ER-stress mediated apoptosis in a variety of" exact="cancer" post="types.46 ER is chiefly involved in protein folding, post-translational"/>
 <result pre="the first time in response to Brv-A treatment in any" exact="cancer" post="type. In various cell types, NADPH oxidases are imperative"/>
 <result pre="previously published findings.17 It is previously reported that fate of" exact="cancer" post="cells in case of overproduction of ROS is dependent"/>
 <result pre="wound healing assay and evaluated its effect on biomarkers of" exact="cancer" post="invasion and metastasis, i.e. MMP-2 and COX-2. We found"/>
 <result pre="role of Brv-A in inhibition of constitutive STAT3 activation by" exact="suppression" post="of upstream tyrosine kinases. Brv-A has also been remarked"/>
 <result pre="research paper. Hydrazinyldiene-chroman-2,4-diones in inducing growth arrest and apoptosis in" exact="breast cancer" post="cells: synergism with doxorubicin and correlation with physicochemical properties."/>
 <result pre="paper. Hydrazinyldiene-chroman-2,4-diones in inducing growth arrest and apoptosis in breast" exact="cancer" post="cells: synergism with doxorubicin and correlation with physicochemical properties."/>
 <result pre="arrest and apoptosis through activation of ROS/JNK pathway in human" exact="breast cancer" post="cells. Toxicol Lett. 2014;227(1):65–73. doi:10.1016/j.toxlet.2014.03.01524680927 3.FerlayJ, ShinHR, BrayF, FormanD,"/>
 <result pre="and apoptosis through activation of ROS/JNK pathway in human breast" exact="cancer" post="cells. Toxicol Lett. 2014;227(1):65–73. doi:10.1016/j.toxlet.2014.03.01524680927 3.FerlayJ, ShinHR, BrayF, FormanD,"/>
 <result pre="ShinHR, BrayF, FormanD, MathersC, ParkinDM. Estimates of worldwide burden of" exact="cancer" post="in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–2917. doi:10.1002/ijc.2551621351269"/>
 <result pre="Int J Cancer. 2010;127(12):2893–2917. doi:10.1002/ijc.2551621351269 4.PorterP. &quot;Westernizing&quot; women’s risks? Breast" exact="cancer" post="in lower-income countries. N Engl J Med. 2008;358(3):213–216. doi:10.1056/NEJMp070830718199859"/>
 <result pre="Cancer. 2008;113(8 Suppl):2221–2243. doi:10.1002/cncr.2384418816619 6.LiT, Mello-ThomsC, BrennanPC. Descriptive epidemiology of" exact="breast cancer" post="in China: incidence, mortality, survival and prevalence. Breast Cancer"/>
 <result pre="2008;113(8 Suppl):2221–2243. doi:10.1002/cncr.2384418816619 6.LiT, Mello-ThomsC, BrennanPC. Descriptive epidemiology of breast" exact="cancer" post="in China: incidence, mortality, survival and prevalence. Breast Cancer"/>
 <result pre="melatonin: a novel approach in elevating efficacy of tamoxifen in" exact="breast cancer" post="treatment. Colloids Surf B Biointerfaces. 2016;145:64–71. doi:10.1016/j.colsurfb.2016.04.04227137804 8.SkoniecznaM, HejmoT,"/>
 <result pre="a novel approach in elevating efficacy of tamoxifen in breast" exact="cancer" post="treatment. Colloids Surf B Biointerfaces. 2016;145:64–71. doi:10.1016/j.colsurfb.2016.04.04227137804 8.SkoniecznaM, HejmoT,"/>
 <result pre="oxidases: insights into selected functions and mechanisms of action in" exact="cancer" post="and stem cells. Oxid Med Cell Longev. 2017;2017:9420539. doi:10.1155/2017/942053928626501"/>
 <result pre="ShenH, LinH, LiD. Anthelminthic drug niclosamide sensitizes the responsiveness of" exact="cervical cancer" post="cells to paclitaxel via oxidative stress-mediated mTOR inhibition. Biochem"/>
 <result pre="LinH, LiD. Anthelminthic drug niclosamide sensitizes the responsiveness of cervical" exact="cancer" post="cells to paclitaxel via oxidative stress-mediated mTOR inhibition. Biochem"/>
 <result pre="product, inhibits janus kinase activity and blocks STAT3 signaling in" exact="cancer" post="cells. PLoS ONE. 2013;8(5):e63697. doi:10.1371/journal.pone.006369723704931 17.WangJ, LiM, CuiX, et"/>
 <result pre="ChenS. Brevilin A induces cell cycle arrest and apoptosis in" exact="nasopharyngeal carcinoma." post="Front Pharmacol. 2019;10:594. doi:10.3389/fphar.2019.0059431178739 20.DiW, KhanD-M, RasulA, et al."/>
 <result pre="constitutive NF-κB activation and induces reactive oxygen species-mediated apoptosis in" exact="osteosarcoma" post="U2OS cells through mitochondrial dysfunction. Oncol Rep. 2014;32. 21.MehmoodT,"/>
 <result pre="inhibits NF-кB and STAT3 activation and induces apoptosis in HepG2" exact="liver cancer" post="cells via oxidative stress. J Cancer. 2017;8(18):3707–3717. doi:10.7150/jca.20239 23.LaurindoFRM,"/>
 <result pre="NF-кB and STAT3 activation and induces apoptosis in HepG2 liver" exact="cancer" post="cells via oxidative stress. J Cancer. 2017;8(18):3707–3717. doi:10.7150/jca.20239 23.LaurindoFRM,"/>
 <result pre="induces apoptosis, inhibits STAT3 activation and augments doxorubicin toxicity in" exact="prostate cancer" post="cells. Int J Med Sci. 2018;15(8):832–839. doi:10.7150/ijms.2327030008594 31.JingwenZ, SeokAK,"/>
 <result pre="apoptosis, inhibits STAT3 activation and augments doxorubicin toxicity in prostate" exact="cancer" post="cells. Int J Med Sci. 2018;15(8):832–839. doi:10.7150/ijms.2327030008594 31.JingwenZ, SeokAK,"/>
 <result pre="model. Antioxid Redox Signal. 2016;24(11):575–589. doi:10.1089/ars.2015.641826649526 32.KariaP, PatelKV, RathodSSP. Breast" exact="cancer" post="amelioration by Butea monosperma in-vitro and in-vivo. J Ethnopharmacol."/>
 <result pre="ATO-induced apoptosis in MCF-7 cells: proposing novel therapeutic potential for" exact="breast cancer." post="Biomed Pharmacother. 2016;83:456–465. doi:10.1016/j.biopha.2016.07.00427427852 34.JiHF, LiXJ, ZhangHY. Natural products"/>
 <result pre="to new and powerful drug combinations in the fight against" exact="cancer" post="and dementia?EMBO Rep. 2009;10(3):194–200. doi:10.1038/embor.2009.1219229284 35.GarrawayLA, JännePA. Circumventing cancer"/>
 <result pre="against cancer and dementia?EMBO Rep. 2009;10(3):194–200. doi:10.1038/embor.2009.1219229284 35.GarrawayLA, JännePA. Circumventing" exact="cancer" post="drug resistance in the era of personalized medicine. Cancer"/>
 <result pre="2012;2(3):214. doi:10.1158/2159-8290.CD-12-001222585993 36.SinghAK, AryaRK, MaheshwariS, et al. Tumor heterogeneity and" exact="cancer" post="stem cell paradigm: updates in concept, controversies and clinical"/>
 <result pre="induces apoptosis through a mitochondrial/caspase and NF-kappaB pathway in human" exact="leukemia" post="HL60 cells. Biomed Pharmacother. 2008;62(6):401–409. doi:10.1016/j.biopha.2007.10.01018077129 39.KhanM, MaryamA, QaziJI,"/>
 <result pre="Targeting apoptosis and multiple signaling pathways with Icariside II in" exact="cancer" post="cells. Int J Biol Sci. 2015;11(9):1100–1112. doi:10.7150/ijbs.1159526221076 40.KhanM, MaryamA,"/>
 <result pre="Biol Sci. 2015;11(9):1100–1112. doi:10.7150/ijbs.1159526221076 40.KhanM, MaryamA, ZhangH, MehmoodT, MaT. Killing" exact="cancer" post="with platycodin D through multiple mechanisms. J Cell Mol"/>
 <result pre="2016;20(3):389–402. doi:10.1111/jcmm.2016.20.issue-326648178 41.AsbyDJ, RadigoisMG, WilsonDC, et al. Triggering apoptosis in" exact="cancer" post="cells with an analogue of cribrostatin 6 that elevates"/>
 <result pre="overload by alantolactone prompts oxidative DNA damage and apoptosis in" exact="colorectal cancer" post="cells. Int J Mol Sci. 2016;17(4):558. doi:10.3390/ijms1704055827089328 45.JiYB, QuZY,"/>
 <result pre="by alantolactone prompts oxidative DNA damage and apoptosis in colorectal" exact="cancer" post="cells. Int J Mol Sci. 2016;17(4):558. doi:10.3390/ijms1704055827089328 45.JiYB, QuZY,"/>
 <result pre="2016;17(4):558. doi:10.3390/ijms1704055827089328 45.JiYB, QuZY, ZouX. Juglone-induced apoptosis in human gastric" exact="cancer" post="SGC-7901 cells via the mitochondrial pathway. Exp Toxicol Pathol."/>
 <result pre="IkappaBalpha and the nuclear translocation of STAT3-NFkappaB complexes in starved" exact="cancer" post="cells. Exp Mol Med. 2016;48:e231. doi:10.1038/emm.2016.1727151455 50.GarciaR, BowmanTL, NiuG,"/>
 <result pre="et al. Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231" exact="breast cancer" post="cell invasion and metastasis in vitro and in vivo."/>
 <result pre="al. Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231 breast" exact="cancer" post="cell invasion and metastasis in vitro and in vivo."/>
</results>
